Probiotic mixture KF attenuates age-dependent memory deficit and lipidemia in fischer 344 rats

Journal of Microbiology and Biotechnology

Volumn 25, Issue 9, 2015, Pages 1532-1536

  Jeong, Jin Ju ^a   Kim, Kyung Ah ^a   Ahn, Young Tae ^b   Sim, Jae Hun ^b   Woo, Jae Yeon ^a   Huh, Chul Sung ^c   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea Yakult Co   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Aging; Lactobacillus curvatus; Lactobacillus plantarum; Lipidemia; Memory deficit

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; DOUBLECORTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN; PROBIOTIC AGENT; PROBIOTIC MIXTURE KF; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; RAPAMYCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FISCHER 344 RAT; HIPPOCAMPUS; HYPERLIPIDEMIA; LACTIC ACID BACTERIUM; LACTOBACILLUS CURVATUS; LACTOBACILLUS PLANTARUM; MALE; MEMORY DISORDER; NONHUMAN; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; Y-MAZE TEST; ANIMAL; BLOOD; DRUG EFFECTS; HYPERLIPIDEMIAS; LACTOBACILLUS; MEMORY DISORDERS; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ANIMALS; CHOLESTEROL, HDL; HIPPOCAMPUS; HYPERLIPIDEMIAS; LACTOBACILLUS; MEMORY DISORDERS; PROBIOTICS; RATS, INBRED F344; TRIGLYCERIDES;

EID: 84941929713     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1505.05002     Document Type: Article

References (21)

1. Bubici C, Papa S, Dean K, Franzoso G. 2006. Mutual crosstalk between reactive oxygen species and nuclear factorkappa B: molecular basis and biological significance. Oncogene 25: 6731-6748
2. Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. 2014. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern. Emerg. Med. 9: 365-373
3. Chapple IL. 1997. Reactive oxygen species and antioxidants in inflammatory diseases. J. Clin. Periodontol. 24: 287-296
4. Chung H, Lee E, Choi Y, Kim J, Kim D, Zou Y, et al. 2011. Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J. Dent. Res. 90: 830-840
5. Craft S. 2005. Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging 26: 65-69
6. Fitzgerald PJ, Seemann JR, Maren S. 2014. Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res. Bull. 105: 46-60
7. Hirsch E, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel P. 2003. The role of glial reaction and inflammation in Parkinson’s disease. Ann. NY Acad. Sci. 991: 214-228
8. Jang SE, Hyam SR, Han MJ, Kim SY, Lee BG, Kim DH. 2013. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. J. Appl. Microbiol. 115: 888-896
9. Jeong JJ, Kim KA, Jang SE, Woo JY, Han MJ, Kim DH. 2015. Orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS One 10: e0116533
10. Luine V, Frankfurt M. 2013. Interactions between estradiol, BDNF and dendritic spines in promoting memory. Neuroscience 239: 34-45
11. McGeer PL, McGeer EG. 2004. Inflammation and the degenerative diseases of aging. Ann. NY Acad. Sci. 1035: 104-116
12. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. 2011. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer Dement. 7: 263-269
13. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, et al. 2013. Proinflammatory cytokines, aging, and age-related diseases. J. Am. Med. Dir. Assoc. 14: 877-882
14. Morelli L. 2014. Yogurt, living cultures, and gut health. Am. J. Clin. Nutr. 99: 1248S-1250S.
15. Neff F, Flores-Dominguez D, Ryan DP, Horsch M, Schröder S, Adler T, et al. 2013. Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Invest. 123: 3272-3291
16. Park DY, A hn YT, Park SH, H uh C S, Y oo SR, Yu R, et al. 2013. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 8: e59470
17. Peterson CT, Sharma V, Elmén L, Peterson SN. 2015. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin. Exp. Immunol. 179: 363-377
18. Sarter M, Bruno JP. 2004. Developmental origins of the agerelated decline in cortical cholinergic function and associated cognitive abilities. Neurobiol. Aging 25: 1127-1139
19. Terry AV, Buccafusco JJ. 2003. The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Therap. 306: 821-827
20. Woo JY, Gu W, Kim KA, Jang SE, Han MJ, Kim DH. 2014. Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a D-galactose-induced accelerated aging mouse model. Anaerobe 27: 22-26
21. Yu BP, Yang R. 1996. Critical evaluation of the free radical theory of aging. Ann. NY Acad. Sci. 786: 1-11.